Comparing the Effect of Vaginal Misoprostol With Dinoprostone in Term Pregnancies

This study is not yet open for participant recruitment.

Verified by Hormozgan University of Medical Sciences, February 2007

First Received: February 6, 2007 Last Updated: May 31, 2007 History of Changes

Sponsored by:	Hormozgan University of Medical Sciences
Information provided by:	Hormozgan University of Medical Sciences
ClinicalTrials.gov Identifier:	NCT00432588

Purpose

Hypothesis (H0): Labor duration and obstetric complications are not significantly different in the three groups (misoprostol-dinoprostone-oxytocin).

Condition	Intervention	Phase
Preeclampsia Fetal Death Fetal Membranes, Premature Rupture	Drug: misoprostol Drug: dinoprostone	Phase I Phase II

Study Type:	Interventional
Study Design:	Treatment, Randomized, Open Label, Active Control, Single Group Assignment, Safety/Efficacy Study

Resource links provided by NLM:

Drug Information available for: Misoprostol Dinoprostone

U.S. FDA Resources

Eligibility

Genders Eligible for Study:

Female

Criteria

Inclusion Criteria:

Term pregnancy
Singleton
Vertex
Bishop score below 6

Exclusion Criteria:

History of drug reaction
Medical disease
IUGR
Oligohydramnios
Vaginal bleeding
Fetal anomaly
Uterine scar

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00432588

Locations

Iran, Islamic Republic of
Shariaty Maternity Hospital
Tehran, Iran, Islamic Republic of

Sponsors and Collaborators

Hormozgan University of Medical Sciences

Investigators

Principal Investigator:	Mitra Ahmad Soltani	Hormozgan University of Medical Sciences
Study Chair:	Minoo Rajaee Lari, Perinatologist - Obs and Gyn	Department of Obs and Gyn - HUMS

More Information

Additional Information:

Related Info This link exits the ClinicalTrials.gov site

No publications provided

Study ID Numbers:	Misoprostol vs Dinoprostone
Study First Received:	February 6, 2007
Last Updated:	May 31, 2007
ClinicalTrials.gov Identifier:	NCT00432588 History of Changes
Health Authority:	United States: Food and Drug Administration

Keywords provided by Hormozgan University of Medical Sciences:

IUFD
POSTTERM
ROM

Study placed in the following topic categories:

Death
Pregnancy Complications
Eclampsia
Misoprostol
Obstetric Labor Complications
Pre-Eclampsia
Rupture

Fetal Membranes, Premature Rupture
Preeclampsia
Fetal Death
Hypertension, Pregnancy-Induced
Dinoprostone
Hypertension

Additional relevant MeSH terms:

Death
Pregnancy Complications
Oxytocics
Misoprostol
Physiological Effects of Drugs
Gastrointestinal Agents
Obstetric Labor Complications
Pre-Eclampsia
Reproductive Control Agents
Abortifacient Agents, Nonsteroidal

Fetal Membranes, Premature Rupture
Pharmacologic Actions
Fetal Death
Hypertension, Pregnancy-Induced
Dinoprostone
Pathologic Processes
Therapeutic Uses
Anti-Ulcer Agents
Abortifacient Agents

ClinicalTrials.gov processed this record on September 02, 2009